The first type III domain of fibronectin is associated with the expression of cytokines within the lung tumor microenvironment

Journal of Cancer

Volumn 2, Issue 1, 2011, Pages 478-483

  Zheng, Mingzhe ^a   Jones, David M ^a   Horzempa, Carol ^a   Prasad, Aparna ^a   McKeown Longo, Paula J ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Cytokine; Fibronectin; Inflammation; Lung cancer

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; FIBRONECTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; RECOMBINANT PROTEIN; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUNG FIBROBLAST; LUNG SQUAMOUS CELL CARCINOMA; LUNG TUMOR; MICROENVIRONMENT; MYOFIBROBLAST; TUMOR IMMUNOLOGY;

EID: 84872153665     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.2.478     Document Type: Article

References (25)

1. Jemal A, Siegl R, Ward E, Hao Y, Xu J, Murray T et al. Cancer statistics, 2008. CA Cancer J Clin. 2008; 58(2):71-96.
2. Houghton AM, Mouded M, Shapiro SD. Common origins of lung cancer and COPD. Nature Med. 2008; 14:1023-4.
3. Mackinnon AC, Kopatz J., Sethi T. The molecular and cellular biology of lung cancer: identifying novel therapeutic strategies. Brit Med Bulletin. 2010; 95(47):61.
4. Lee G, Walser TC, Dubinett SM. Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer. Current Opin Pulmon Med. 2009; 15:303-7.
5. Liu G, Meng X, Jih Y, Bai J, Zhao Y, Cui X et al. Inhibitory role of focal adhesion kinase on anoikis in the lung cancer cell A549. Cell Biol Int. 2008; 32:663-70.
6. Jia D, Yan M, Wang X, Liang L, Liu L, Kong H et al. Development of a highly metastatic model that reveals a crucial role of fibronectin in lung cancer cell migration and invasion. BMC Cancer. 2010; 10:364.
7. Malik G., Knowles LM, Dhir R, Xu S, Yang S, Ruoslahti E et al. Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion. Cancer Res. 2010; 70:4327-34.
8. Roman J, Rizenthaler JD, Roser-Page S, Sun X, Han S. α5β1-integrin expression is essential for tumor progression in experimental lung cancer. Am J Respir Cell Mol Biol. 2010; 43:684-91.
9. Zheng Y, Ritzenthaler JD, Roman J, Han S. Nicotine stimulates human lung cancer cell growth by inducing fibronectin expression. Am J Respir Cell Mol Biol. 2007; 376:681-90.
10. Hartmann TN, Burger JA, Glodek A, Fujii N, Burger M. CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells. Oncogene. 2005; 24:4462-71.
11. Liu F, Mih JD, Shea BS, Kho AT, Sharif AS, Tager AM et al. Feedback amplifications of fibrosis through matrix stiffening and COX-2 suppression. J Cell Biol. 2010; 190:693-708.
12. Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009; 139:891-906.
13. Antia M, Baneys G, Kubow KE, Vogel V. Fibronectin in aging extracellular matrix fibrils is progressively unfolded by cells and elicits an enhanced rigidity response. Farady Discuss. 2008; 139:229-49.
14. Gao M, Craig D, Lequin O, Campbell ID, Vogel V, Schulten K. Structure and functional significance of mechanically unfolded fibronectin type III1 intermediates. Proc Natl Acad Sci. 2003; 100:14784-9.
15. Klein RM, Zheng M, Ambesi A, van de Water L, McKeown-Longo PJ. Stimulation of extracellular matrix remodeling by the first type III repeat in fibronectin. J Cell Sci. 2003; 116:4663-74.
16. Gui L, Wojciechowski K, Gildner CD, Nedelkovska H, Hocking DC. Identification of the heparin-binding determinants within fibronectin repeat III1: role in cell spreading and growth. J Biol Chem. 2006; 281:34816-25.
17. Raman D, Baugher PJ, Thu YM, Richmond A. Role of chemokines in tumor growth. Cancer Lett. 2007; 256:137-65.
18. Jones CP, Pitchford SC, Lloyd CM, Rankin SM. CXCR2 mediates the recruitment of endothelial progenitor cells during allergic airways remodeling. Stem Cells. 2009; 27:3074-81.
19. Yi M, Ruoslahti E. A fibronectin fragment inhibits tumor growth, angiogenesis, and metastasis. Proc Natl Acad Sci. 2001; 98:620-4.
20. Ambesi A, Klein RM, Pumiglia KM, McKeown-Longo PJ. Anastellin, a fragment of the first type III repeat of fibronectin, inhibits extracellular signal-regulated kinase and causes G1 arrest in human microvessel endothelial cells. Cancer Res. 2005; 65:148-56.
21. Ambesi A, McKeown-Longo PJ. Anastellin, the angiostatic fibronectin peptide, is a selective inhibitor of lysophospholipid signaling. Mol Cancer Res. 2009; 7(2):255-65.
22. You R, Zheng M, McKeown-Longo PJ. The first type III repeat in fibronectin activates an inflammatory pathway in dermal fibroblasts. J Biol Chem. 2010; 285:36255-9.
23. Lorne E, Dupont H, Abraham E. Toll-like receptors 2 and 4: initiators of non-septic inflammation in critical care medicine? Inten Care Med. 2010; 36:1826-35.
24. Stewart CR, Stuart LM, Wilkinson K, van Gils JM, Deng J, Halle A et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol. 2010; 11:155-61.
25. Piccinini AM, Midwood KS. DAMPening inflammation by modulating TLR signalling. Mediators of Inflammation. 2010; Epub.